Fig. 1From: The novel approach for non-invasive diagnostic biomarkers from an early stage of NAFLD to advanced fibrosisShowing the conclusive current trend followed by the patient of nonalcoholic fatty liver disease based on their epidemiological data globally. The nonobese patient shows a very lower prevalence rate to develop the NAFLD when we compare with patients with already type 2 diabetes mellitus and obesity patientBack to article page